Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 4Recruiting 4Completed 3Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 26Myelodysplastic Syndromes 13Recurrence 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelomonocytic, Chronic 4Leukemia 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Thrombocythemia, Essential 1Systemic Mastocytosis With an Associated Hematologic Neoplasm 1Primary Myelofibrosis 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myeloid Malignancies 1Myelodysplastic-Myeloproliferative Diseases 1Lymphodepleting Chemotherapy 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Hypomethylating Agent 1Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1Hodgkin Disease 1Hematologic Neoplasms 1Congenital Bone Marrow Failure Syndromes 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

Rituximab 41Cyclophosphamide 37Magnetic Resonance Spectroscopy 22Specimen Handling 20Prednisone 19Doxorubicin 19polatuzumab vedotin 18Lenalidomide 17Biopsy 15fludarabine 13Oxaliplatin 13Gemcitabine 13Vincristine 12zanubrutinib 11Immunotherapy, Adoptive 11Etoposide 10glofitamab 8obinutuzumab 7axicabtagene ciloleucel 7Prednisolone 7ibrutinib 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Leukapheresis 6Injections 6Ifosfamide 6CT-P10 6Bendamustine Hydrochloride 6orelabrutinib 5loncastuximab tesirine 5fludarabine phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Large B-Cell, Diffuse × Decitabine × Clear all
NCT03418038 2026-04-16

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Mayo Clinic

Phase 2 Recruiting
80 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

NCT06803693 2025-12-08

Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

Ruijin Hospital

Phase 2 Recruiting
152 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05348213 2024-10-23

R-ICE+X

Ruijin Hospital

Phase 2 Recruiting
76 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05351346 2023-03-24

Genotype-guided Treatment in DLBCL

Ruijin Hospital

Phase 3 Recruiting
1,100 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡